Literature DB >> 25392528

PARP-1 mediates LPS-induced HMGB1 release by macrophages through regulation of HMGB1 acetylation.

Zhiyong Yang1, Li Li1, Lijuan Chen1, Weiwei Yuan1, Liming Dong1, Yushun Zhang1, Heshui Wu1, Chunyou Wang2.   

Abstract

The high-mobility group box protein 1 (HMGB1) is increasingly recognized as an important inflammatory mediator. In some cases, the release of HMGB1 is regulated by poly(ADP-ribose) polymerase-1 (PARP-1), but the mechanism is still unclear. In this study, we report that PARP-1 activation contributes to LPS-induced PARylation of HMGB1, but the PARylation of HMGB1 is insufficient to direct its migration from the nucleus to the cytoplasm; PARP-1 regulates the translocation of HMGB1 to the cytoplasm through upregulating the acetylation of HMGB1. In mouse bone marrow-derived macrophages, genetic and pharmacological inhibition of PARP-1 suppressed LPS-induced translocation and release of HMGB1. Increased PARylation was accompanied with the nucleus-to-cytoplasm translocation and release of HMGB1 upon LPS exposure, but PARylated HMGB1 was located at the nucleus, unlike acetylated HMGB1 localized at the cytoplasm in an import assay. PARP inhibitor and PARP-1 depletion decreased the activity ratio of histone acetyltransferases to histone deacetylases that elevated after LPS stimulation and impaired LPS-induced acetylation of HMGB1. In addition, PARylation of HMGB1 facilitates its acetylation in an in vitro enzymatic reaction. Furthermore, reactive oxygen species scavenger (N-acetyl-l-cysteine) and the ERK inhibitor (FR180204) impaired LPS-induced PARP activation and HMGB1 release. Our findings suggest that PARP-1 regulates LPS-induced acetylation of HMGB1 in two ways: PARylating HMGB1 to facilitate the latter acetylation and increasing the activity ratio of histone acetyltransferases to histone deacetylases. These studies revealed a new mechanism of PARP-1 in regulating the inflammatory response to endotoxin.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25392528     DOI: 10.4049/jimmunol.1400359

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Endoplasmic reticulum stress regulates oxygen-glucose deprivation-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS.

Authors:  Hai-Feng Wang; Zong-Qi Wang; Ye Ding; Mei-Hua Piao; Chun-Sheng Feng; Guang-Fan Chi; Yi-Nan Luo; Peng-Fei Ge
Journal:  CNS Neurosci Ther       Date:  2017-10-16       Impact factor: 5.243

2.  Activated protein C inhibits lipopolysaccharide-mediated acetylation and secretion of high-mobility group box 1 in endothelial cells.

Authors:  Xiaofeng Cai; Indranil Biswas; Sumith R Panicker; Hemant Giri; Alireza R Rezaie
Journal:  J Thromb Haemost       Date:  2019-04-09       Impact factor: 5.824

3.  PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.

Authors:  Qian Li; Zhuo-Ming Li; Shu-Ya Sun; Lu-Ping Wang; Pan-Xia Wang; Zhen Guo; Han-Wei Yang; Jian-Tao Ye; Jing Lu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-07-20       Impact factor: 6.150

4.  JNK Activation Contributes to Oxidative Stress-Induced Parthanatos in Glioma Cells via Increase of Intracellular ROS Production.

Authors:  Linjie Zheng; Chen Wang; Tianfei Luo; Bin Lu; Hongxi Ma; Zijian Zhou; Dong Zhu; Guangfan Chi; Pengfei Ge; Yinan Luo
Journal:  Mol Neurobiol       Date:  2016-05-16       Impact factor: 5.590

5.  PARP Inhibition Prevents Ethanol-Induced Neuroinflammatory Signaling and Neurodegeneration in Rat Adult-Age Brain Slice Cultures.

Authors:  Nuzhath Tajuddin; Hee-Yong Kim; Michael A Collins
Journal:  J Pharmacol Exp Ther       Date:  2018-01-16       Impact factor: 4.030

Review 6.  Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.

Authors:  Maria Esperanza Rodriguez-Ruiz; Ilio Vitale; Kevin J Harrington; Ignacio Melero; Lorenzo Galluzzi
Journal:  Nat Immunol       Date:  2019-12-23       Impact factor: 25.606

7.  Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.

Authors:  Rebecca A Sosa; Allyson Q Terry; Fady M Kaldas; Yi-Ping Jin; Maura Rossetti; Takahiro Ito; Fang Li; Richard S Ahn; Bita V Naini; Victoria M Groysberg; Ying Zheng; Antony Aziz; Jessica Nevarez-Mejia; Ali Zarrinpar; Ronald W Busuttil; David W Gjertson; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  Hepatology       Date:  2020-10-30       Impact factor: 17.425

Review 8.  PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Inflamm Res       Date:  2021-05-06

Review 9.  ADP-ribosylation in evasion, promotion and exacerbation of immune responses.

Authors:  Maria Manuela Rosado; Claudio Pioli
Journal:  Immunology       Date:  2021-04-12       Impact factor: 7.215

10.  A genome-wide screen uncovers multiple roles for mitochondrial nucleoside diphosphate kinase D in inflammasome activation.

Authors:  Orna Ernst; Jing Sun; Bin Lin; Balaji Banoth; Michael G Dorrington; Jonathan Liang; Benjamin Schwarz; Kaitlin A Stromberg; Samuel Katz; Sharat J Vayttaden; Clinton J Bradfield; Nadia Slepushkina; Christopher M Rice; Eugen Buehler; Jaspal S Khillan; Daniel W McVicar; Catharine M Bosio; Clare E Bryant; Fayyaz S Sutterwala; Scott E Martin; Madhu Lal-Nag; Iain D C Fraser
Journal:  Sci Signal       Date:  2021-08-03       Impact factor: 9.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.